Cabozantinib in Men With Castration-Resistant Prostate Cancer

Clinical trial NCT01703065 · TERMINATED

Trial details

NCT number: NCT01703065
Sponsor: University of Washington
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of the Prostate Castration-resistant Prostate Cancer Recurrent Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer

Start date: 2013-06-18
Primary completion: 2015-02-02
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.